ArticleBreast (Edinburgh, Scotland)2026

Optimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer.

Carmine Valenza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.